GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Northland Biotech Co Ltd (BJSE:430047) » Definitions » COGS-to-Revenue

Beijing Northland Biotech Co (BJSE:430047) COGS-to-Revenue : 0.47 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Northland Biotech Co COGS-to-Revenue?

Beijing Northland Biotech Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥7.58 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥16.12 Mil.

Beijing Northland Biotech Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.47.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Beijing Northland Biotech Co's Gross Margin % for the three months ended in Mar. 2024 was 52.96%.


Beijing Northland Biotech Co COGS-to-Revenue Historical Data

The historical data trend for Beijing Northland Biotech Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Northland Biotech Co COGS-to-Revenue Chart

Beijing Northland Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.35 0.10 0.27 0.35 0.51

Beijing Northland Biotech Co Quarterly Data
Mar19 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.52 0.50 0.55 0.47

Beijing Northland Biotech Co COGS-to-Revenue Calculation

Beijing Northland Biotech Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=30.316 / 59.675
=0.51

Beijing Northland Biotech Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=7.583 / 16.122
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Northland Biotech Co  (BJSE:430047) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Beijing Northland Biotech Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 7.583 / 16.122
=52.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Beijing Northland Biotech Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Beijing Northland Biotech Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Northland Biotech Co (BJSE:430047) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Shangdi Kaikai Road, A406, Zhongguancun Biomedical Park, Haidian District, Beijing, CHN, 100085
Beijing Northland Biotech Co Ltd is a biopharmaceutical company specializing in the research and development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs.

Beijing Northland Biotech Co (BJSE:430047) Headlines

No Headlines